Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Estimated Burden of COVID-19 Illnesses, Medical Visits, Hospitalizations, and Deaths in the US From October 2022 to September 2024.
Journal: JAMA internal medicine
Published: January 06, 2026
Influenza A virus resistance to 4'-fluorouridine coincides with viral attenuation in vitro and in vivo.
Journal: bioRxiv : the preprint server for biology
Published: October 31, 2023
4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.
Journal: Science (New York, N.Y.)
Published: December 02, 2021
4'-Fluorouridine is a broad-spectrum orally efficacious antiviral blocking respiratory syncytial virus and SARS-CoV-2 replication.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2021
Progress and pitfalls of a year of drug repurposing screens against COVID-19.
Journal: Current opinion in virology
Published: March 09, 2021
Resveratrol Inhibits Venezuelan Equine Encephalitis Virus Infection by Interfering with the AKT/GSK Pathway.
Journal: Plants (Basel, Switzerland)
Published: December 07, 2020
Structural Insight into Paramyxovirus and Pneumovirus Entry Inhibition.
Journal: Viruses
Published: March 07, 2020
Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation.
Structure of a paramyxovirus polymerase complex reveals a unique methyltransferase-CTD conformation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 21, 2020
Repurposing Papaverine as an Antiviral Agent against Influenza Viruses and Paramyxoviruses.
Journal: Journal of virology
Published: November 05, 2019
Last Updated: 09/26/2026